Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 1
2011 2
2013 1
2014 3
2015 3
2016 8
2017 6
2018 10
2019 7
2020 8
2021 6
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer.
D'Journo XB, Boulate D, Fourdrain A, Loundou A, van Berge Henegouwen MI, Gisbertz SS, O'Neill JR, Hoelscher A, Piessen G, van Lanschot J, Wijnhoven B, Jobe B, Davies A, Schneider PM, Pera M, Nilsson M, Nafteux P, Kitagawa Y, Morse CR, Hofstetter W, Molena D, So JB, Immanuel A, Parsons SL, Larsen MH, Dolan JP, Wood SG, Maynard N, Smithers M, Puig S, Law S, Wong I, Kennedy A, KangNing W, Reynolds JV, Pramesh CS, Ferguson M, Darling G, Schröder W, Bludau M, Underwood T, van Hillegersberg R, Chang A, Cecconello I, Ribeiro U Jr, de Manzoni G, Rosati R, Kuppusamy M, Thomas PA, Low DE; International Esodata Study Group. D'Journo XB, et al. JAMA Surg. 2021 Sep 1;156(9):836-845. doi: 10.1001/jamasurg.2021.2376. JAMA Surg. 2021. PMID: 34160587 Free PMC article. Clinical Trial.
Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial.
Zylstra J, Whyte GP, Beckmann K, Pate J, Santaolalla A, Gervais-Andre L, Russell B, Maisey N, Waters J, Tham G, Lagergren J, Green M, Kelly M, Baker C, Van Hemelrijck M, Goh V, Gossage J, Browning M, Davies A. Zylstra J, et al. Br J Sports Med. 2022 Apr;56(7):402-409. doi: 10.1136/bjsports-2021-104243. Epub 2022 Feb 1. Br J Sports Med. 2022. PMID: 35105604 Clinical Trial.
Telephone risk-based eligibility assessment for low-dose CT lung cancer screening.
Dickson JL, Hall H, Horst C, Tisi S, Verghese P, Mullin AM, Teague J, Farrelly L, Bowyer V, Gyertson K, Bojang F, Levermore C, Anastasiadis T, Sennett K, McCabe J, Devaraj A, Nair A, Navani N, Callister ME, Hackshaw A; SUMMIT Consortium; Quaife SL, Janes SM. Dickson JL, et al. Thorax. 2022 Oct;77(10):1036-1040. doi: 10.1136/thoraxjnl-2021-218634. Epub 2022 Jul 21. Thorax. 2022. PMID: 35863766 Free PMC article.
Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohort.
Tisi S, Creamer AW, Dickson J, Horst C, Quaife S, Hall H, Verghese P, Gyertson K, Bowyer V, Levermore C, Hacker AM, Teague J, Farrelly L, Nair A, Devaraj A, Hackshaw A, Hurst JR; SUMMIT Consortium; Janes S. Tisi S, et al. BMJ Open Respir Res. 2023 Jun;10(1):e001664. doi: 10.1136/bmjresp-2023-001664. BMJ Open Respir Res. 2023. PMID: 37321665 Free PMC article.
Transition from esophagectomy to endoscopic therapy for early esophageal cancer.
Dunn JM, Reyhani A, Santaolalla A, Zylstra J, Gimson E, Pennington M, Baker C, Kelly M, Van Hemelrijck M, Lagergren J, Zeki SS, Gossage JA, Davies AR. Dunn JM, et al. Among authors: zylstra j. Dis Esophagus. 2022 Mar 12;35(3):doab047. doi: 10.1093/dote/doab047. Dis Esophagus. 2022. PMID: 34260693
59 results